Int J Angiol
DOI: 10.1055/s-0042-1743564
Case Report

Recognizing Kounis Syndrome, the Unusual Possible Culprit of Acute Coronary Syndrome: A Rare Case Report

1   Internship Doctor, R. Syamsudin SH Regional Public Hospital, Sukabumi, West Java, Indonesia
,
Dena Karina Firmansyah
2   Department of Cardiology and Vascular Medicine, R. Syamsudin SH Regional Public Hospital, Sukabumi, West Java, Indonesia
› Author Affiliations
Funding None.

Abstract

Kounis syndrome encompasses acute coronary syndrome features associated with severe vasospasm of the coronary artery. It is related to allergic anaphylactic reaction triggered by the release of inflammatory cells and mediators. This entity, however, is often not properly diagnosed. In this report, we aimed to discuss a case of Kounis syndrome mimicking acute coronary syndrome. We presented a 58-year-old man with dyspnea, chest pain, dizziness, and itchiness 30 minutes following sodium diclofenac ingestion. His physical examination was remarkable for shock with hypoxia and features of anaphylactic reaction. An urgent electrocardiogram was obtained, manifesting deep ST-segment depression in anterolateral leads with ST elevation of aVR, which hinted a severe three-vessel disease or left main disease. Allergic acute coronary syndrome was suspected. Thus, the patient was managed with fluid resuscitation, epinephrine, and corticosteroid injection along with acute coronary syndrome treatment algorithm with a favorable clinical response. One-hour serial ECG showed complete resolution of ST depression with aVR normalization. This pointed to possible acute coronary spasm. No further coronary intervention was performed, the patient was discharged after 2 days in good condition and planned for further cardiac evaluation during follow-up. Kounis syndrome is an intriguing process caused by the presence of two disease entities that must be treated simultaneously. The difficulty in treating this condition stems from the fact that treating one of both entities may aggravate the other. Thus, a comprehensive approach and health education are strongly advised to ensure that this condition does not reoccur in the future.

Consent for Publication

Informed consent was obtained from the patient for being included in the case report. No patient identity particulars have been disclosed.




Publication History

Article published online:
19 April 2022

© 2022. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Memon S, Chhabra L, Masrur S, Parker MW. Allergic acute coronary syndrome (Kounis syndrome). Proc Bayl Univ Med Cent 2015; 28 (03) 358-362
  • 2 Rodríguez-Ruiz C, Puig-Carrión G, Delgado-Nieves A, López-Candales A. Kounis syndrome: a more commonly encountered cause of acute coronary syndrome. Heart Views 2019; 20 (03) 122-125
  • 3 Kounis NG, Mazarakis A, Tsigkas G, Giannopoulos S, Goudevenos J. Kounis syndrome: a new twist on an old disease. Future Cardiol 2011; 7 (06) 805-824
  • 4 Kounis NG. Coronary hypersensitivity disorder: the Kounis syndrome. Clin Ther 2013; 35 (05) 563-571
  • 5 Sueda S, Sasaki Y, Habara H, Kohno H. Editorial: Kounis syndrome (allergic angina and allergic myocardial infarction) for cardiologists. J Cardiol Cases 2015; 12 (04) 110-112
  • 6 Gangadharan V, Bhatheja S, Al Balbissi K. Kounis syndrome - an atopic monster for the heart. Cardiovasc Diagn Ther 2013; 3 (01) 47-51
  • 7 Kounis NG. Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med 2016; 54 (10) 1545-1559
  • 8 Kounis NG, Koniari I, Velissaris D, Tzanis G, Hahalis G. Kounis syndrome—not a single-organ arterial disorder but a multisystem and multidisciplinary disease. Balkan Med J 2019; 36 (04) 212-221
  • 9 Christodoulidis G, Vittorio TJ, Fudim M, Lerakis S, Kosmas CE. Inflammation in coronary artery disease. Cardiol Rev 2014; 22 (06) 279-288
  • 10 Doğan V, Mert GÖ, Biteker FS, Mert KU, Biteker M. Treatment of Kounis syndrome. Int J Cardiol 2015; 181: 133-134
  • 11 Cardona V, Ansotegui IJ, Ebisawa M. et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J 2020; 13 (10) 100472
  • 12 Deoker A, Lehker A, Mukherjee D. Updates in anti-anginal and anti-ischemic therapies for acute coronary syndromes. Curr Cardiol Rep 2020; 22 (10) 126
  • 13 Amsterdam EA, Wenger NK, Brindis RG. et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64 (24) e139-e228
  • 14 Blanca-Lopez N, Soriano V, Garcia-Martin E, Canto G, Blanca M. NSAID-induced reactions: classification, prevalence, impact, and management strategies. J Asthma Allergy 2019; 12: 217-233
  • 15 Picaud J, Beaudouin E, Renaudin JM. et al. Anaphylaxis to diclofenac: nine cases reported to the Allergy Vigilance Network in France. Allergy 2014; 69 (10) 1420-1423
  • 16 Cornejo-Garcia JA, Blanca-López N, Doña I. et al. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Drug Metab 2009; 10 (09) 971-980
  • 17 Kim YJ, Lim KH, Kim MY. et al. Cross-reactivity to acetaminophen and celecoxib according to the type of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Immunol Res 2014; 6 (02) 156-162